Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing

di Klion, Amy D., Robyn, Jamie, Maric, Irina, Fu, Weiming, Schmid, Laura, Lemery, Steven, Noel, Pierre, Law, Melissa A., Hartsell, Marilyn, Talar-Williams, Cheryl, Fay, Michael P., Dunbar, Cynthia E., Nutman, Thomas B.
Pubblicazione 2007